Ahad A. Sadiq
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Ravi SalgiaAlessandro MorabitoNiels ReinmuthAlona ZerHoward WestDavey B. DanielAlan SandlerMichael McCleod
- Topics
- Lung Cancer Treatments and Mutations (9 papers)Cancer Immunotherapy and Biomarkers (5 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Ahad A. Sadiq
17 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.0k
- Immunology 223
- Molecular Biology 204
- Cancer Research 147
Countries citing papers authored by Ahad A. Sadiq
This map shows the geographic impact of Ahad A. Sadiq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahad A. Sadiq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahad A. Sadiq more than expected).
Fields of papers citing papers by Ahad A. Sadiq
This network shows the impact of papers produced by Ahad A. Sadiq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahad A. Sadiq. The network helps show where Ahad A. Sadiq may publish in the future.
Co-authorship network of co-authors of Ahad A. Sadiq
This figure shows the co-authorship network connecting the top 25 collaborators of Ahad A. Sadiq. A scholar is included among the top collaborators of Ahad A. Sadiq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahad A. Sadiq. Ahad A. Sadiq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 116 | |
| 4 | Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trialbreakdown → | 1137 |
| 5 | 9 | |
| 6 | 2 | |
| 7 | 43 | |
| 8 | 11 | |
| 9 | 7 | |
| 10 | 8 | |
| 11 | 29 | |
| 12 | 8 | |
| 13 | 152 | |
| 14 | 3 | |
| 15 | 3 | |
| 16 | 6 | |
| 17 | 27 |
About Ahad A. Sadiq
Ahad A. Sadiq is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Oncology, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.0k citations) and Immunology (223 citations). Ahad A. Sadiq has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Ravi Salgia, Alessandro Morabito, Niels Reinmuth, Alona Zer, Howard West, Davey B. Daniel, Alan Sandler, Michael McCleod, Federico Cappuzzo and Henry Jacob Conter. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.